Table 2.
Cancer risk for T2DM patients by sex and cancer site
| Females | Males | ||||||
|---|---|---|---|---|---|---|---|
| Cancer site | Obs | SIR | 95% CI | Obs | SIR | 95% CI | |
| Head & Neck | [C00-C14; C30-C32] | 2 | 0.40 | (0.05, 1.46) | 14 | 0.75 | (0.41, 1.26) |
| Stomach | [C16] | 10 | 1.07 | (0.51, 1.97) | 8 | 0.55 | (0.24, 1.08) |
| Colorectum | [C18-C21] | 27 | 0.94 | (0.62, 1.36) | 44 | 1.11 | (0.81, 1.49) |
| Liver | [C22] | 7 | 2.40 | (0.96, 4.94) | 20 | 2.71 | (1.65, 4.18) |
| Pancreas | [C25] | 16 | 1.78 | (1.02, 2.89) | 18 | 1.87 | (1.11, 2.96) |
| Lung | [C33-C34] | 15 | 0.79 | (0.44, 1.30) | 45 | 0.92 | (0.67, 1.24) |
| Melanoma | [C43] | 9 | 0.82 | (0.37, 1.55) | 11 | 0.70 | (0.35, 1.25) |
| Breast | [C50] | 72 | 1.13 | (0.88, 1.42) | |||
| Breast postmenopausal | [C50] | 70 | 1.18 | (0.92, 1.49) | |||
| Cervix uteri | [C53] | 10 | 1.81 | (0.87, 3.32) | |||
| Corpus uteri | [C54] | 24 | 1.79 | (1.15, 2.66) | |||
| Ovary | [C56] | 7 | 0.63 | (0.25, 1.29) | |||
| Prostate | [C61] | 83 | 0.85 | (0.68, 1.05) | |||
| Bladder | [C67] | 4 | 0.89 | (0.24, 2.29) | 16 | 1.10 | (0.63, 1.79) |
| Kidney | [C64-C65] | 10 | 1.45 | (0.70, 2.67) | 19 | 1.65 | (0.99, 2.57) |
| Brain | [C47; C70-C72] | 0 | 0 | (0.00, 1.18) | 3 | 0.73 | (0.15, 2.13) |
| Thyroid | [C73] | 8 | 1.65 | (0.71, 3.25) | 1 | 0.30 | (0.01, 1.67) |
| Haem&Lymph1) | [C81-C85; C88; C90-C96; D45-D47] | 26 | 1.28 | (0.84, 1.87) | 21 | 0.78 | (0.48, 1.18) |
| All cancer sites except NMSC | [C00-C97; D45-D47; exc. C44] | 234 | 1.05 | (0.92, 1.20) | 291 | 0.93 | (0.82, 1.04) |
1)Neoplasms in the haematologic/lymphatic system.